Dr. Lal PathLabs Ltd
LALPATHLABBSE 539524Healthcare Service ProviderMkt cap ₹33,680 Cr
Whole group, including subsidiaries — the figures companies headline.
Revenue · Q1 FY27
₹798 Cr
YoY +19.1%QoQ +13.5%
Net profit · Q1 FY27
₹171 Cr
YoY +27.2%QoQ +29.0%
Net margin · Q1 FY27
21.4%
+1.4 pts vs Q1 FY26
Net profit · FY26
₹510 Cr
YoY +3.6%
Quarterly results
| ₹ Cr | Q1 FY27 Apr–Jun 2026 | Q4 FY26 Jan–Mar 2026 | Q3 FY26 Oct–Dec 2025 | Q2 FY26 Jul–Sep 2025 | Q1 FY26 Apr–Jun 2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 798 | 703 | 660 | 731 | 670 | +19.1% |
| Other income | 31.90 | 24.00 | 24.40 | 24.80 | 28.10 | +13.5% |
| Total income | 830 | 727 | 684 | 755 | 698 | +18.9% |
| Profit before tax | 229 | 160 | 124 | 204 | 181 | +26.3% |
| Tax | 58.20 | 27.90 | 32.90 | 51.40 | 47.10 | +23.6% |
| Net profit | 171 | 132 | 91.40 | 152 | 134 | +27.2% |
| Net margin | 21.4% | 18.8% | 13.8% | 20.8% | 20.0% |
Annual results
| ₹ Cr | FY26 Apr 2025–Mar 2026 | FY25 Apr 2024–Mar 2025 | FY24 Apr 2023–Mar 2024 | FY23 Apr 2022–Mar 2023 | FY22 Apr 2021–Mar 2022 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 2,763 | 2,461 | 2,227 | 2,017 | 2,087 | +12.2% |
| Other income | 101 | 93.40 | 69.20 | 41.70 | 52.50 | +8.5% |
| Total income | 2,864 | 2,555 | 2,296 | 2,059 | 2,140 | +12.1% |
| Profit before tax | 669 | 625 | 506 | 344 | 475 | +7.1% |
| Tax | 159 | 133 | 143 | 103 | 125 | +20.2% |
| Net profit | 510 | 492 | 362 | 241 | 350 | +3.6% |
| Net margin | 18.4% | 20.0% | 16.3% | 11.9% | 16.8% |
BIC's take
We haven't covered Dr. Lal PathLabs Ltd yet. Browse our sector reports →
Source: BSE filings · Data as of 2 Oct 2026, 5:10 pm IST· ₹ crore unless stated. Covers BSE 500 companies only. Consolidated figures include subsidiaries; standalone is the parent company alone. Growth is shown only against a positive base. Not investment advice — check the company's full filing before acting.